Helsinn Birex Pharmaceuticals ^None

Helsinn Birex Pharmaceuticals is a Swiss biopharmaceutical group that focuses on cancer supportive care and oncology therapeutics. They aim to provide the best supportive care for cancer patients by investing in a fully integrated targeted therapy structure to develop, manufacture, and commercialize small molecules in precision medicine. The company is based in Ireland and has been active since May 1978. They employ 10 people and their main line of business activity is the manufacture of basic pharmaceutical products.